Scinai Immunotherapeutics Statistics
Total Valuation
SCNI has a market cap or net worth of $2.37 million. The enterprise value is $2.49 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCNI has 933,679 shares outstanding. The number of shares has increased by 106.41% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 933,679 |
| Shares Change (YoY) | +106.41% |
| Shares Change (QoQ) | +46.50% |
| Owned by Insiders (%) | 20.02% |
| Owned by Institutions (%) | 15.18% |
| Float | 610,760 |
Valuation Ratios
The trailing PE ratio is 0.43.
| PE Ratio | 0.43 |
| Forward PE | n/a |
| PS Ratio | 3.11 |
| Forward PS | n/a |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 0.52 |
| EV / Sales | 3.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.32 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 177.37% and return on invested capital (ROIC) is -38.49%.
| Return on Equity (ROE) | 177.37% |
| Return on Assets (ROA) | -34.92% |
| Return on Invested Capital (ROIC) | -38.49% |
| Return on Capital Employed (ROCE) | -74.20% |
| Revenue Per Employee | $21,226 |
| Profits Per Employee | $154,710 |
| Employee Count | 31 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.96% in the last 52 weeks. The beta is 2.23, so SCNI's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -45.96% |
| 50-Day Moving Average | 2.81 |
| 200-Day Moving Average | 3.38 |
| Relative Strength Index (RSI) | 46.31 |
| Average Volume (20 Days) | 17,030 |
Short Selling Information
| Short Interest | 4,954 |
| Short Previous Month | 772 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, SCNI had revenue of $658,000 and earned $4.80 million in profits. Earnings per share was $5.95.
| Revenue | 658,000 |
| Gross Profit | -580,000 |
| Operating Income | -8.64M |
| Pretax Income | -19.70M |
| Net Income | 4.80M |
| EBITDA | -6.99M |
| EBIT | -8.64M |
| Earnings Per Share (EPS) | $5.95 |
Full Income StatementBalance Sheet
The company has $1.96 million in cash and $2.09 million in debt, giving a net cash position of -$122,000 or -$0.13 per share.
| Cash & Cash Equivalents | 1.96M |
| Total Debt | 2.09M |
| Net Cash | -122,000 |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 9.98M |
| Book Value Per Share | 5.10 |
| Working Capital | 585,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.34 million and capital expenditures -$12,000, giving a free cash flow of -$6.35 million.
| Operating Cash Flow | -6.34M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | -6.35M |
| FCF Per Share | -$6.80 |
Full Cash Flow StatementMargins
Gross margin is -88.15%, with operating and profit margins of -1,312.77% and 728.88%.
| Gross Margin | -88.15% |
| Operating Margin | -1,312.77% |
| Pretax Margin | 728.88% |
| Profit Margin | 728.88% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |